68 related articles for article (PubMed ID: 36241925)
21. Epigenetic regulation of LINC01270 in breast cancer progression by mediating LAMA2 promoter methylation and MAPK signaling pathway.
Li S; Hu J; Li G; Mai H; Gao Y; Liang B; Wu H; Guo J; Duan Y
Cell Biol Toxicol; 2023 Aug; 39(4):1359-1375. PubMed ID: 36241925
[TBL] [Abstract][Full Text] [Related]
22. Silence of lncRNA MIAT-mediated inhibition of DLG3 promoter methylation suppresses breast cancer progression via the Hippo signaling pathway.
Li D; Hu X; Yu S; Deng S; Yan M; Sun F; Song J; Tang L
Cell Signal; 2020 Sep; 73():109697. PubMed ID: 32593652
[TBL] [Abstract][Full Text] [Related]
23. Down-regulated expression of LINC00518 prevents epithelial cell growth and metastasis in breast cancer through the inhibition of CDX2 methylation and the Wnt signaling pathway.
Wang HB; Wei H; Wang JS; Li L; Chen AY; Li ZG
Biochim Biophys Acta Mol Basis Dis; 2019 Mar; 1865(3):708-723. PubMed ID: 30611858
[TBL] [Abstract][Full Text] [Related]
24. LINC00858 knockdown inhibits gastric cancer cell growth and induces apoptosis through reducing WNK2 promoter methylation.
Du J; Liang Y; Li J; Zhao JM; Lin XY
Cell Oncol (Dordr); 2020 Aug; 43(4):709-723. PubMed ID: 32447640
[TBL] [Abstract][Full Text] [Related]
25. Correction to: Epigenetic regulation of LINC01270 in breast cancer progression by mediating LAMA2 promoter methylation and MAPK signaling pathway.
Li S; Hu J; Li G; Mai H; Gao Y; Liang B; Wu H; Guo J; Duan Y
Cell Biol Toxicol; 2023 Dec; 39(6):3345. PubMed ID: 37578667
[No Abstract] [Full Text] [Related]
26. Epidermal growth factor-like domain 7 regulates breast cancer cell proliferation and vascular endothelial growth factor expression via the p38MAPK signaling pathway.
Zhou B; Wang J
Am J Transl Res; 2021; 13(4):2608-2616. PubMed ID: 34017420
[TBL] [Abstract][Full Text] [Related]
27. Methylation-dependent MCM6 repression induced by LINC00472 inhibits triple-negative breast cancer metastasis by disturbing the MEK/ERK signaling pathway.
Shao G; Fan X; Zhang P; Liu X; Huang L; Ji S
Aging (Albany NY); 2021 Feb; 13(4):4962-4975. PubMed ID: 33668040
[TBL] [Abstract][Full Text] [Related]
28. Association between lincRNA expression and overall survival for patients with triple-negative breast cancer.
Ping J; Huang S; Wu J; Bao P; Su T; Gu K; Cai H; Guo X; Lipworth L; Blot WJ; Zheng W; Cai Q; Shu XO
Breast Cancer Res Treat; 2021 Apr; 186(3):769-777. PubMed ID: 33247368
[TBL] [Abstract][Full Text] [Related]
29. Silencing of long non-coding RNA LINC01270 inhibits esophageal cancer progression and enhances chemosensitivity to 5-fluorouracil by mediating GSTP1methylation.
Li N; Zhao Z; Miao F; Cai S; Liu P; Yu Y; Wang B
Cancer Gene Ther; 2021 May; 28(5):471-485. PubMed ID: 33199829
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of DNMT1 and ERRα crosstalk suppresses breast cancer via derepression of IRF4.
Vernier M; McGuirk S; Dufour CR; Wan L; Audet-Walsh E; St-Pierre J; Giguère V
Oncogene; 2020 Oct; 39(41):6406-6420. PubMed ID: 32855526
[TBL] [Abstract][Full Text] [Related]
31. Knockdown of circ_0000512 Inhibits Cell Proliferation and Promotes Apoptosis in Colorectal Cancer by Regulating miR-296-5p/RUNX1 Axis.
Wang L; Wu H; Chu F; Zhang L; Xiao X
Onco Targets Ther; 2020; 13():7357-7368. PubMed ID: 32821119
[TBL] [Abstract][Full Text] [Related]
32. LncRNA H19 promotes triple-negative breast cancer cells invasion and metastasis through the p53/TNFAIP8 pathway.
Li Y; Ma HY; Hu XW; Qu YY; Wen X; Zhang Y; Xu QY
Cancer Cell Int; 2020; 20():200. PubMed ID: 32514245
[TBL] [Abstract][Full Text] [Related]
33. LncRNA TROJAN promotes proliferation and resistance to CDK4/6 inhibitor via CDK2 transcriptional activation in ER+ breast cancer.
Jin X; Ge LP; Li DQ; Shao ZM; Di GH; Xu XE; Jiang YZ
Mol Cancer; 2020 May; 19(1):87. PubMed ID: 32393270
[TBL] [Abstract][Full Text] [Related]
34. LncRNA BCRT1 promotes breast cancer progression by targeting miR-1303/PTBP3 axis.
Liang Y; Song X; Li Y; Chen B; Zhao W; Wang L; Zhang H; Liu Y; Han D; Zhang N; Ma T; Wang Y; Ye F; Luo D; Li X; Yang Q
Mol Cancer; 2020 May; 19(1):85. PubMed ID: 32384893
[TBL] [Abstract][Full Text] [Related]
35. Breast Cancer: Current Perspectives on the Disease Status.
Fahad Ullah M
Adv Exp Med Biol; 2019; 1152():51-64. PubMed ID: 31456179
[TBL] [Abstract][Full Text] [Related]
36. Screening key lncRNAs for human lung adenocarcinoma based on machine learning and weighted gene co-expression network analysis.
Wang Y; Fu J; Wang Z; Lv Z; Fan Z; Lei T
Cancer Biomark; 2019; 25(4):313-324. PubMed ID: 31322548
[TBL] [Abstract][Full Text] [Related]
37. Non-coding RNAs as potential therapeutic targets in breast cancer.
Tomar D; Yadav AS; Kumar D; Bhadauriya G; Kundu GC
Biochim Biophys Acta Gene Regul Mech; 2020 Apr; 1863(4):194378. PubMed ID: 31048026
[TBL] [Abstract][Full Text] [Related]
38. Mitogen-Activated Protein Kinase (MAPK): New Insights in Breast Cancer.
Lu H; Guo Y; Gupta G; Tian X
J Environ Pathol Toxicol Oncol; 2019; 38(1):51-59. PubMed ID: 30806290
[TBL] [Abstract][Full Text] [Related]
39. Expression and methylation status of LAMA2 are associated with the invasiveness of nonfunctioning PitNET.
Wang RQ; Lan YL; Lou JC; Lyu YZ; Hao YC; Su QF; Ma BB; Yuan ZB; Yu ZK; Zhang HQ; Wang DS; Zhu TZ; Ding Y; Zhang N; Zhang B
Ther Adv Endocrinol Metab; 2019; 10():2042018818821296. PubMed ID: 30728939
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
